Against this background, this long-term retrospective study investigated the impact of the relationship between Hb levels at the time of renal biopsy and IFTA on the risks for renal composite events and all-cause mortality in Japanese patients with type 2 diabetes and biopsy-proven diabetic nephropathy. This evidence concerns the gene GSTM1 and diabetic kidney disease.